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Background: Niemann-Pick disease type C (NPC) is caused by defects in cholesterol efflux from lysosomes due to
mutations of genes coding for NPC1 and NPC2 proteins. As a result, massive accumulation of unesterified
cholesterol in late endosomes/lysosomes is observed. At the level of the organism these cholesterol metabolism
disorders are manifested by progressive neurodegeneration and hepatosplenomegaly. Until now filipin staining of
cholesterol deposits in cells has been widely used for NPC diagnostics. In this report we present an alternative
method for cholesterol visualization and estimation using a cholesterol-binding bacterial toxin, perfringolysin O.
Methods: To detect cholesterol deposits, a recombinant probe, perfringolysin O fused with glutathione
S-transferase (GST-PFO) was prepared. GST-PFO followed by labeled antibodies or streptavidin was applied for
immunofluorescence and immunoelectron microscopy to analyze cholesterol distribution in cells derived from NPC
patients. The identity of GST-PFO–positive structures was revealed by a quantitative analysis of their colocalization
with several organelle markers. Cellular ELISA using GST-PFO was developed to estimate the level of unesterified
cholesterol in NPC cells.
Results: GST-PFO recognized cholesterol with high sensitivity and selectivity, as demonstrated by a protein/lipid
overlay assay and surface plasmon resonance analysis. When applied to stain NPC cells, GST-PFO decorated
abundant deposits of cholesterol in intracellular vesicles that colocalized with filipin-positive structures. These
cholesterol deposits were resistant to 0.05%-0.2% Triton X-100 used for cells permeabilization in the staining
procedure. GST-PFO-stained organelles were identified as late endosomes/lysosomes based on their colocalization
with LAMP-1 and lysobisphosphatidic acid. On the other hand, GST-PFO did not colocalize with markers of the
Golgi apparatus, endoplasmic reticulum, peroxisomes or with actin filaments. Only negligible GST-PFO staining was
seen in fibroblasts of healthy individuals. When applied to cellular ELISA, GST-PFO followed by anti-GST-peroxidase
allowed a semiquantitative analysis of cholesterol level in cells of NPC patients. Binding of GST-PFO to NPC cells
was nearly abolished after extraction of cholesterol with methyl-β-cyclodextrin.
Conclusions: Our data indicate that a recombinant protein GST-PFO can be used to detect cholesterol accumulated in
NPC cells by immunofluorescence and cellular ELISA. GST-PFO can be a convenient and reliable probe for revealing
cholesterol deposits in cells and can be useful in diagnostics of NPC disease.
Keywords: Niemann-Pick C disease, Lipid storage diseases, Cholesterol-binding proteins, Filipin, Perfringolysin O* Correspondence: a.sobota@nencki.gov.pl
1Department of Cell Biology, Nencki Institute of Experimental Biology, 3
Pasteur St., 02-093 Warsaw, Poland
Full list of author information is available at the end of the article
© 2014 Kwiatkowska et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public
Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
Kwiatkowska et al. Orphanet Journal of Rare Diseases 2014, 9:64 Page 2 of 16
http://www.ojrd.com/content/9/1/64Background
Niemann-Pick disease type C (NPC) is a lysosomal sto-
rage disorder caused by accumulation of unesterified
cholesterol in cells of the brain, liver, etc., that occurs
with an estimated frequency of 1 in 120 000 individuals
[1-4]. This value can be underestimated, since atypical
phenotypes may not be properly diagnosed [4]. Cho-
lesterol is internalized by cells from serum mainly as a
constituent of low density lipoprotein (LDL) by clathrin-
mediated endocytosis. The LDL is directed to lysosomes
where it is hydrolyzed and free unesterified cholesterol is
released [5]. The cholesterol is transported from lyso-
somes to the plasma membrane and the endoplasmic
reticulum where it undergoes esterification. Simultan-
eously, de novo synthesis of cholesterol and LDL uptake
are down-regulated [2,6,7].
The NPC disease is caused by mutations of NPC1 or
NPC2 genes coding for lysosomal proteins – NPC1 and
NPC2. About 95% of NPC cases are linked to mutations
in the NPC1 gene [8,9]. NPC1 is a transmembrane lyso-
somal protein while NPC2 is localized in the lumen of
lysosomes [10,11]. The NPC1 and NPC2 proteins are en-
gaged in transporting free cholesterol and some accom-
panying glycolipids from lysosomes to other cellular
compartments [6,12,13]. In addition to cholesterol accu-
mulation in lysosomes its synthesis and metabolism are
also affected leading to disturbances in the synthesis of
steroid hormones and in the assembly of cellular mem-
branes. Predominant symptoms of NPC disease are pro-
gressive neurodegeneration and hepatosplenomegaly.
The severity of symptoms of NPC disease varies, but
typically the disease leads to death in the second decade
of life [3,14]. The neuropathological lesions in NPC pa-
tients can be reduced by application of an inhibitor of
glucosylceramide synthase, the main enzyme involved in
glycosphingolipid synthesis [15].
Presently, detection of NPC disease requires skin bi-
opsy, cultivation of fibroblasts and their staining with
filipin, a fluorescent polyene antibiotic which binds free
cholesterol [3,16]. However, this approach requires UV
excitation and filipin fluorescence is prone to photo-
bleaching, which constrains its application in NPC diag-
nostics [17,18]. Other methods of NPC diagnosis are
also considered [19]. Recently, a new approach for detec-
tion of NPC disease based on LC-MS/MS analysis of ox-
idized forms of cholesterol in the serum has been
proposed [20], but a wider application of this sensitive
and specific method is limited by the availability of the
sophisticated equipment.
Alternative visualization of cholesterol deposits in
NPC cells could in principle be also based on the appli-
cation of protein toxins of microbial origin which spe-
cifically recognize free cholesterol and can be used as
probes for cell staining without the drawbacks of filipin.About twenty toxins produced by Gram-positive bacteria
belong to the family of cholesterol-binding cytolysins
[21,22]. Among such bacterial toxins special attention
has been paid to perfringolysin O (PFO) produced by
Clostridium perfringens [23,24]. PFO oligomerizes upon
binding to membrane cholesterol and leads to pore for-
mation provided the cholesterol content exceeds 30
mol% [25,26]. A biotinylated proteolytic derivative of
PFO, named BCθ, of molecular mass of 57 kDa, has been
used to stain NPC cells. In those studies, cells were fixed
with 4% paraformaldehyde and exposed to BCθ without
cellular membrane permeabilization, yielding intracellular
staining [27,28]. Taking into account the relatively high
molecular mass of BCθ, the mechanism of its entry into
cells and the nature of “the cholesterol-rich domains” de-
tected by BCθ [27] remain unknown.
In this study we prepared PFO fused with glutathione
S-transferase (GST) and used the recombinant protein
to detect cholesterol-rich organelles in Triton X-100-
permeabilized NPC and healthy-donor cells. The GST-
PFO-positive vesicles, found only in NPC cells, also stained
with filipin, antibodies against lysosomal-associated mem-
brane protein 1 (LAMP-1) and lysobisphosphatidic acid
(LBPA), indicating that the procedure detected accumula-




The studies were performed on fibroblasts derived from
NPC patients and from healthy donors. The NPC patients
had been diagnosed on the basis of clinical, cytochemical
(Department of Genetics, Institute of Psychiatry and
Neurology, Warsaw, Poland) and/or molecular parameters
(NZOZ Genomed, Warsaw, Poland). To obtain fibroblast
cultures, skin biopsies were dissected and cells were
grown for up to 7 passages in DMEM medium containing
10% FBS, 50 U/ml penicillin, 50 μg/ml streptomycin,
0.2 μg/ml amphotericin B at 37°C, 5% CO2. Prior to ex-
periments cells were transferred to DMEM medium with
delipidated 10% FBS and cultured for 72 h [29]. The de-
lipidated FBS was prepared according to Cham and
Knowles [30] using organic solvents (di-isopropyl ether
and n-butanol, 40:60, v:v) and filtered throughout a
0.22 μm sterile filter. The procedure removed 96% of the
original cholesterol content in FBS, as determined by the
Cholesterol DST kit (Alpha Diagnostics). This study was
conducted in accordance with the Helsinki Declaration.
Ethical approval of the study was requested at the local
Bioethical Committee of the Institute of Psychiatry and
Neurology in Warsaw, Poland. According to the informa-
tion obtained from the Committee, the usage of biological
material taken from patients, which was excessive after
diagnostics procedures, does not demand a special
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formed consent for such action. Patients gave their signed
informed consent for the use of their cells in the scientific
experiments after anonimization of the material samples.
For cholesterol depletion, cells cultured in medium
containing delipidated 10% FBS were fixed, permeabi-
lized as described further, and exposed for 1 h to 3 mM
methyl-β-cyclodextrin (Sigma) in PBS at 37°C. To trigger
uptake of LDL, cells were cultured in the presence of
delipidated 10% FBS (72 h) and subsequently incubated
with 10 μg/ml DiI-LDL (Biomed. Technology) in DMEM/
delipidated 10% FBS for 5 h at 37°C.Preparation of recombinant PFO
A synthetic gene for perfringolysin O of Clostridium
perfringens was prepared by GenScript (USA) basing on
cDNA sequence No. CP000246.1 at NCBI. The sequence
was optimized for expression in E. coli. The synthe-
sized gene was devoid of a leader sequence coding for
28 N-terminal amino acids to ensure intracellular accu-
mulation of the expressed protein. The product was
cloned by the vendor into pUC57 plasmid. To obtain
PFO with a GST tag at the N-terminus, the construct
was cloned into pGEX4T vector using BamHI and
EcoRI sites. To allow potential removal of the GST tag,
the construct was modified by introducing the sequence
5′ GAA AAC CTG TAT TTT CAG GGC 3′ encoding
the ENLYFQG motif recognized by Tobacco Etch Virus
(TEV) protease [31].
The recombinant vector was transformed into BL-21
(DE3) strain of E. coli. Bacteria were grown at 37°C in
LB medium containing 100 μg/ml ampicillin to OD =
0.6, when 0.5 mM IPTG was added. The culture was
continued at 18°C for 20 h, bacteria were harvested,
washed in PBS and lysed in the presence of 0.35 mg/ml
lysozyme (10 min, 4°C). The obtained suspension was
supplemented with 1% Triton X-100 and sonicated on
ice for 15 min at 0.3 cycle, amplitude 33%, using an
UP200S Hielscher sonifier (Germany). The lysate was
clarified by centrifugation at 20 000 × g for 40 min at 4°C
and loaded onto a Glutathione-Sepharose 4B column (bio-
WORLD). GST-PFO was eluted from the column with
10 mM glutathione, 10 mM DTT, 50 mM Tris, pH 8.0.
The GST protein was prepared as described earlier [32].
The presence and purity of the recombinant proteins in
column fractions were examined by 10% SDS-PAGE.
Fractions containing highest amounts of GST-PFO or
GST were pooled and filtered over Amicon Ultra-15 cen-
trifugal filter units to remove glutathione and concentrate
the protein. Samples containing about 0.45 mg/ml GST-
PFO or 0.6 mg/ml GST in 5 mM DTT, 50 mM Tris,
pH 8.0 were supplemented with 20% sucrose and frozen
in liquid nitrogen.Protein-lipid overlay assay
The analysis was performed essentially as described ear-
lier [33] with modifications. The following lipids were
used: semisynthetic bovine brain sphingomyelin (SM),
C16-ceramide, cholesterol, dioleoylphosphatidylcholine
(DOPC), dipalmitoylphosphatidylcholine (DPPC) and di-
palmitoylphosphatidylethanolamine (DPPE) (all from
Sigma). The lipids were dissolved in chloroform:methanol:
H2O (1:1:0.3) and 1 μl of the solution containing 25–500
pmoles of lipid was spotted onto a 0.45-μm nitrocellulose
membrane. The membrane was pressed with a hot block
at 60°C for 5 s according to Taki and Ishikawa [34],
blocked with 1% gelatin and 1% polyvinylpyrrolidone and
incubated for 45 min at 20°C with 1 μg/ml GST-PFO in
PBS buffer containing 0.03% Tween-20. After washing,
the membrane was exposed for 45 min to chicken anti-
GST IgY-peroxidase (Rockland). Immunoreactive spots
were visualized with the SuperSignal West Pico chemilu-
minescence substrate (Pierce).
Carboxyfluorescein release from liposomes
Liposomes composed of (i) cholesterol:SM:DOPC (mol%
40:30:30), (ii) cholesterol:DPPE:DOPC (mol% 40:30:30),
(iii) SM:DPPC:DOPC (mol% 40:30:30) or (iv) DPPE:
DPPC:DOPC (mol% 40:30:30) loaded with 10 mM 6-
carboxyfluorescein were prepared as described earlier
[32] with modifications. Lipids were mixed, dried under
nitrogen, resuspended in PBS containing 10 mM 6-
carboxyfluorescein and sonicated in nitrogen atmosphere
(15 min, 4°C, 0.3 cycle with amplitude 33% in the UP200S
Hielscher sonifier). Pelleted liposomes (2000 × g, 10 min)
were resuspended in PBS at a total concentration of lipids
of 1 mM. Release of 6-carboxyfluorescein from the lipo-
somes was induced by 15 μg/ml GST-PFO and measured
at Em/Ex = 490/520 nm on a Spex spectrofluorimeter
(Jobin-Yvone). The maximal efflux of 6-carboxyfluorescein
was determined in the presence of 0.2% Triton X-100.
Surface plasmon resonance (SPR)
The analysis was performed on large unilamellar vesi-
cles, 100 nm in diameter, containing cholesterol:DOPC,
DPPE:DPPC or SM:DPPC (mol% 50:50) and prepared as
described by Kulma et al. [32]. The liposomes were depos-
ited on the L1 chip of a BIACore X apparatus (BIACore,
GE Healthcare) at a flow rate of 1 μl/min for 10 min.
Binding experiments were performed at 10 μg/ml GST-
PFO or 10–60 μg/ml GST in 150 mM NaCl, 30 mM Tris,
pH 8.0, at a flow rate of 30 μl/min. After 10 min (binding
phase) the samples were washed for another 10 min (dis-
sociation phase).
Determination of total cellular cholesterol
Cells, 3×106/sample, were scraped from dishes after 72 h
of culturing in DMEM/delipidated 10% FBS, washed
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panol (3:2, v:v), sonicated and incubated for 15 min at
20°C with shaking. Extracted lipids were dried under N2
and resuspended in 50 μl isopropanol (45 min, 20°C).
Aliquots of 30 μl were mixed with 300 μl of Cholesterol
DST reagent and processed according to the manufac-
turer’s instructions (Alpha Diagnostics). Protein content
in “cell skeletons” remaining after lipid extraction was
estimated by Bradford Ultra reagent (Expedeon Ltd) and
measured at 595 nm.
Determination of chitotriosidase activity
The enzyme activity was measured in samples of blood
serum using 4-methylumbelliferyl-β-D-N,N,N’-triacetyl-
chitotriose as a substrate (Sigma) according to [35].
Cellular ELISA
Cells were seeded in DMEM/10% FBS on 96-well plates
at 5×103 cells/well, unless indicated otherwise. After 8 h,
the medium was replaced with DMEM/delipidated 10%
FBS and the cultures were grown for 72 h. Then, the
cells were washed, fixed in 3% paraformaldehyde in
PHEM buffer (60 mM PIPES, 25 mM HEPES, 10 mM
EGTA, 4 mM MgCl2, pH 6.9), washed in PBS buffer, ex-
posed to 50 mM NH4Cl/PBS (5 min, 20°C), washed
again and permeabilized with 0.05% Triton X-100/PBS
for 10 min at 20°C. In a series of experiments cells were
permeabilized with 0.03-0.2% Triton X-100 (10 min,
20°C) or 0.05% digitonin (10 min, 20°C). The detergent
was washed out with PBS and the cells were incubated
for 45 min at 20°C in 3% fish gelatin/PBS followed by
5 μg/ml GST-PFO in PBS buffer containing 1% fish
gelatin (Sigma). When indicated, prior to labeling with
GST-PFO cells were incubated with 3 mM methyl-β-
cyclodextrin for 60 min at 37°C. After washing 5 times in
1% fish gelatin/PBS, the cells were incubated with 2 μg/ml
chicken anti-GST IgY-peroxidase in 1% fish gelatin/PBS
(45 min, 20°C), washed 3 times in 1% fish gelatin/PBS and
3 times in PBS alone. The enzymatic activity of bound
peroxidase was examined in the presence of 0.05 mg/ml
3,3′,5,5′-tetramethylbenzidine and 0.045% H2O2. After
30 min, the reaction was stopped with 1 M H2SO4 and
the absorbance was measured at 450 nm using a Sunrise
Plate Reader (Tecan Group). The results were normalized
against protein content in samples estimated by Bradford
Ultra at 595 nm. Samples were run in parallel with and
without treatment with GST-PFO. The values of 450/595
absorbance obtained in samples not-treated with GST-
PFO were subtracted from the corresponding values of
samples incubated with GST-PFO.
Immunofluorescence studies
Cells (1×104/sample) were seeded on coverslips (15×15
mm) in DMEM containing 10% FBS and after 18 h themedium was replaced with DMEM supplemented with
delipidated 10% FBS and cultured for 72 h. Cells were
washed with PBS, fixed with 3% paraformaldehyde in
PHEM buffer (30 min, 20°C) and processed essentially
as described [36]. Briefly, cells were washed, incubated
with 50 mM NH4Cl/PBS for 5 min at 20°C and per-
meabilized with 0.05% Triton X-100/PBS for 10 min at
4°C. Alternatively, in a series of experiments cells were
permeabilized with 0.05% digitonin/PBS for 10 min at
20°C. After washing in PBS, cells were incubated twice
with 3% fish gelatin in PBS (30 min each incubation).
Next, cells were treated with 5 μg/ml GST-PFO for
45 min at 20°C and washed five times in 0.2% fish gel-
atin/PBS. To detect the probe, the cells were exposed to
goat IgG anti-GST conjugated with biotin (Rockland)
prepared in 0.2% fish gelatin/PBS (45 min, 20°C). In
studies on colocalization of PFO-stained structures, the
anti-GST antibody was accompanied by: (i) rabbit anti-
LAMP-1 IgG (Santa Cruz Biotechnology), (ii) rabbit
anti-golgin-84 IgG (Santa Cruz Biotechnology), (iii) rab-
bit anti-protein disulfide isomerase (PDI; Cell Signa-
ling), (iv) mouse anti-peroxisomal membrane protein 70
(PMP70) (Sigma), (v) mouse anti-LBPA IgG (clone 6C4;
Echelon), or (vi) phalloidin-FITC (Sigma). Unbound
antibodies and phalloidin were washed out five times
with 0.2% fish gelatin/PBS and the samples were incu-
bated for 45 min at 20°C either with streptavidin-TRITC
(Sigma) and goat anti-rabbit IgG F(ab)2-FITC (Jackson
ImmunoResearch) or goat anti-mouse IgG-FITC (ICN).
In some experiments cells were exposed to 25 μg/ml fili-
pin III (Sigma) for 45 min at 20°C in darkness and GST-
PFO was detected using goat IgG anti-GST followed by
donkey anti-goat-Texas Red (Jackson Immunoresearch).
When living cells were exposed to 10 μg/ml DiI-LDL,
they were washed after 5 h at 37°C, fixed with 3% para-
formaldehyde, permeabilized with 0.05% Triton X-100,
incubated with 5 μg/ml GST-PFO followed by the anti-
GST-biotin antibody, as described above and exposed to
streptavidin-FITC (45 min, 20°C; Sigma). After extensive
washing in 0.2% fish gelatin/PBS, samples were mounted
in mowiol/DABCO and examined either under a Nikon
microscope equipped with a DXM1200C digital camera
or under a Leica confocal microscope (TCS SP8 SMD).
TRITC and FITC, TRITC and filipin, DiI-LDL and FITC
were excited in the mode of sequential excitation to ex-
clude cross-over of their fluorescence. Stacks of 8–10
confocal planes were acquired for each analyzed cell.
The setting of photomultipliers were adjusted to obtain
comparable ranges of pixel intensity in each channel,
scan resolution was 1024×1024. Colocalization analysis
was performed on single-plane confocal images using
Leica Application Suite AF software which calculated
the Perason’s correlation coefficient and the overlap co-
efficient [32]. For both signals the intensity threshold
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was applied. At least 20 cells from two independent ex-
periments were analyzed for each variant.
Electron microscopy
For the studies, NPC and control healthy fibroblasts
were grown in 10-cm Petri dishes to confluence and
after washing with PBS, were fixed with 3% formalde-
hyde/0.5% glutaraldehyde in 100 mM sodium phosphate
buffer (pH 7.2) for 30 min at 20°C. Cells were washed
twice with the phosphate buffer, treated with 50 mM
NH4Cl in the buffer (10 min, 20°C), washed and gently
scraped off the dishes. Pelleted cells (2000 × g, 2.5 min)
were dehydrated in an ethanol series (20°C) followed by
incubations in mixtures of LR White resin/ethanol at ra-
tios 1:1, 2:1 and 3:1, each for 1 h. Finally, the samples
were infiltrated with 100% LR White overnight, after
which the resin was exchanged twice (1 h, 20°C). The
samples were polymerized at 56°C for 48 h. Ultrathin
sections were placed on formvar-coated nickel grids and
blocked with 3% fish gelatin in PBS and next in a mix-
ture of 3% BSA and 1% polyvinylpyrrolidone in PBS
(50 min each incubation). Subsequently, the samples
were incubated overnight with 10 μg/ml GST-PFO and
rabbit anti-LAMP-1 antibody in 0.2% fish gelatin/PBS in
a humid atmosphere. After washing five times with 0.2%
fish gelatin/0.05% Tween-20/PBS, the samples were in-
cubated with goat anti-GST IgG-biotin (3.5 h) and after
washing, exposed to goat anti-biotin IgG conjugated
with 6 nm gold particles and donkey anti-rabbit IgG-
10 nm gold (both Aurion) prepared in 0.2% fish gelatin/
0.05% Tween-20/PBS (3 h). After extensive washing: sixFigure 1 Selective recognition of cholesterol by GST-PFO. (A) Protein-l
nitrocellulose membrane and incubated with 1 μg/ml GST-PFO. Immunoreac
release from liposomes of indicated composition induced by 15 μg/ml GST-P
6-carboxyfluorescein released from liposomes by 0.2% Triton X-100. (C) SPR se
of indicated lipid composition immobilized on the surface of sensor chip L1. B
the samples were washed for another 600 s. In (A) and (C) data represent on
experiments is shown. Chol – cholesterol; Cer – ceramide; SM – sphingomyeltimes with 0.2% fish gelatin/0.05% Tween-20/PBS, thrice
with PBS and twice with distilled H2O, the samples were
counterstained with 2.5% uranyl acetate in 50% ethanol
for 15 min in dark, washed with 50% ethanol and distilled
H2O, and stained with lead citrate for 2 min. Finally, the
samples were washed with distilled H2O, dried and exam-
ined under a JEM 1400 (Jeol) electron microscope.
Results
Expression of GST-PFO
In order to obtain a selective cholesterol-binding probe, a
synthetic gene encoding perfringolysin O was cloned in-
frame with the GST-encoding sequence in the pGEX4T
vector. To preclude secretion of the fusion protein, the
PFO sequence was trimmed at the 5′ end by removing the
first 28 amino acids comprising a leader peptide. In
addition, a heptapeptide motif recognized by TEV prote-
ase was introduced between the GST and 28ΔPFO se-
quence allowing potential cleavage of the GST tag. The
GST-PFO fusion protein was expressed in E. coli and puri-
fied by one-step affinity chromatography on Glutathione-
Sepharose; the protein migrated as a 78-kDa band on
SDS-PAGE and was ca. 98% pure (not shown).
In this study the uncleaved GST-PFO protein was used
as the GST tag was useful for detection of PFO in cells.
To assess whether the recombinant GST-PFO protein
selectively recognized and bound cholesterol, a protein-
lipid overlay assay was performed. The probe at 1 μg/ml
detected cholesterol in a dose-dependent manner start-
ing from 25 pmoles of the lipid and with high specificity,
as it did not recognize ceramide or phospholipids such
as sphingomyelin, DOPC, DPPC and DPPE (Figure 1A).ipid overlay assay. Indicated amounts of lipids were spotted on
tive spots were revealed by chemiluminescence. (B) 6-Carboxyfluorescein
FO. The data are expressed as percentage of the total amount of
nsograms of binding of 10 μg/ml GST-PFO or 20 μg/ml GST to liposomes
inding of GST-PFO to liposomes was carried out for 600 s after which
e of three independent experiments; in (B) mean ± SEM from three
in.
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PFO undergoes oligomerization and forms pores respon-
sible for its lytic activity [37]. We found that GST-PFO
displayed lytic activity and released 6-carboxyfluorescein
trapped in cholesterol-containing liposomes regardless
of the composition of the accompanying phospholipids
(Figure 1B). The permeabilizing activity of GST-PFO
confirmed the protein’s specificity – it did not induce
the release of 6-carboxyfluorescein from liposomes de-
void of cholesterol (Figure 1B). When incubated with
sheep erythrocytes, in which cholesterol constitutes
about 30% of the total lipid content [38], GST-PFO in-
duced maximal hemolysis at 200 ng/ml (not shown).
Strong binding of GST-PFO to cholesterol-containing
liposomes was also revealed by surface plasmon reson-
ance analysis (Figure 1C). The binding indicated by a
resonance value of about 2800 RU was stable during
10 minutes of washing of the samples. There was no
binding of GST alone to the liposomes. The binding of
GST-PFO to liposomes devoid of cholesterol was negli-
gible (Figure 1C). The data indicate that GST-tagged
PFO retained selectivity for cholesterol binding charac-
teristic for native PFO [25,26].
GST-PFO and filipin stain the same organelles
Filipin staining is a generally accepted tool for detection
of cholesterol deposits in NPC cells [3,39-41]. We aimed
to characterize PFO as another convenient probe for
visualization and analysis of cholesterol in cells. In fibro-
blasts derived from NPC patients, fixed and perme-
abilized with 0.05% Triton-X100, GST-PFO strongly
stained the abundant perinucler structures (Figure 2A).
After prolonged lipid deprivation, the staining was mod-
erately decreased revealing that the GST-PFO-stained
deposits were located in vesicles (Figure 2B). The pattern
of cell staining by GST-PFO was similar to that shown
by filipin (compare Figure 2A and A’, B and B’; typical
vesicles with clear colocalization are marked by arrows).
However, small vesicles seemed to be decorated more
strongly by GST-PFO than by filipin (Figure 2B’, inset).
The staining of NPC cells with GST-PFO was specific
to the probe since only residual labeling was detected
when GST-PFO was omitted. Simultaneously, choles-
terol deposits were revealed in these cells by filipin
(Figure 2C, C’). Only negligible staining with GST-PFO or
filipin was found in fibroblasts from healthy individuals
(Figures 2D, D’). Together with the selectivity of GST-
PFO for cholesterol demonstrated by physico-chemical
approaches presented in Figure 1, the fluorescence mi-
croscopy data strongly suggest that GST-PFO detects
cholesterol stored in NPC cells.
Beside perinuclear cholesterol deposits, GST-PFO probe
also detected small vesicles located at the cell periphery
which were abundant in NPC cells cultured in a completemedium (Figure 2A). Since these vesicles could corres-
pond to LDL-containing endosomes, NPC cells and fib-
roblasts from healthy individuals were incubated with
10 μg/ml DiI-LDL for 5 h, and subsequently subjected to
GST-PFO co-staining (Figure 3). Confocal microscopy
analysis revealed that in NPC cells, DiI-LDL accumulated
in various amounts within perinuclear vesicles co-labeled
with GST-PFO (Figure 3A-A”). DiI-LDL was also present
in numerous vesicles along an “endocytic track” leading
from the cell periphery toward the perinuclear region.
These vesicles containing DiI-LDL were decorated with
GST-PFO with variable intensity: GST-PFO staining was
absent in vesicles at the start of the “endocytic track” and
increased gradually toward the cell center (Figure 3A”,
inset). The presence of free cholesterol in endocytic veis-
cles can result from disturbances in the lipid distribution
in NPC cells or can indicate that in these cells cholesterol
deesterification starts already in endosomes. In control fi-
broblasts, despite intensive LDL endocytosis, no staining
of LDL-containing vesicles with GST-PFO was detected
(Figure 3B-B”).
The organelles stained by GST-PFO bear markers of late
endosomes and lysosomes
To identify the vesicles stained by GST-PFO in NPC fi-
broblasts, colocalization of the probe with markers of
different cellular compartments was analyzed. Of the
several organelle-specific probes, the LAMP-1-specific
staining of lysosomes overlapped markedly with the
GST-PFO signal (Figure 4A-A”). Magnified confocal op-
tical sections revealed that at the basolateral level,
LAMP-1 and GST-PFO signals were rather separated
but their colocalization increased in the middle part of
the cell (Figure 4A” s1-s4). Individual vesicles displayed
partial overlapping of LAMP-1 and GST-PFO staining
which changed along the vertical axis (Figure 4A” s1-s4,
circles). To estimate the degree of colocalization of GST-
PFO and LAMP-1-positive vesicles, a quantitative analysis
was performed of dual-color confocal images. Two dif-
ferent values were calculated: the Pearson's correlation
coefficient and the overlap coefficient [42]. As seen in
Figure 5, the Pearson’s correlation coefficient for co-
immunostaining of GST-PFO and LAMP was high and
reached 0.59 ± 0.05 (in relation to 1 as the maximal
value). The overlap coefficient of the two fluorescence
patterns was also high (0.64 ± 0.05). We estimated also
colocalization of GST-PFO and filipin staining (see
Figure 4B-B”). The Pearson’s correlation coefficient and
the overlap coefficient for fluorescence generated by these
two probes were as high as 0.53 ± 0.03 and 0.65 ± 0.02,
respectively (Figure 5).
Previous studies indicated that cholesterol-containing
vesicles stained by filipin in NPC cells were rich in LBPA,
a marker of late endosomes-multivesicular bodies [43,44].
Figure 2 GST-PFO labels cholesterol deposits in NPC fibroblasts. (A-C) NPC fibroblasts were cultured in DMEM/10% FBS (A, A’) or in DMEM
supplemented with delipidated 10% FBS for 72 h (B-C’). Inset in (B’) shows an enlargement of a merged image of an area marked in (B, B’).
Colocalization of GST-PFO and filipin staining is in white. Colocalization of the labels is also seen in vesicles marked by arrows in (B, B’). (C, C’)
Omitting GST-PFO during labeling of permeabilized NPC cells yields only traces of non-specific staining with secondary antibodies (C). In these
conditions, filipin detects cholesterol accumulated in the cells (C’). (D-D’) Fibroblasts from a healthy donor were cultured in DMEM/delipidated
10% FBS. Cells were fixed, permeabilized with 0.05% Triton X-100 and incubated with 5 μg/ml GST-PFO followed by secondary antibodies
conjugated with Texas Red (left) or with 25 μg/ml filipin (right) to compare the staining patterns revealed by the two probes. Scale bar, 20 μm.
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labeled and LBPA-rich structures were, however, strongly
impeded by technical conditions of cell staining. Per-
meabilization of cells with 0.05% Triton X-100 which was
optimal for cholesterol detection (see data below) did not
promote visualization of LBPA. In these conditions, only
a sub-population of GST-PFO-positive vesicles was la-
beled with the anti-LPBA antibody (Figure 6A-A”). The
Pearson’s correlation coefficient and the overlap coefficient
for the two lipids reached 0.36 ± 0.04 and 0.52 ± 0.04,respectively (Figure 5). In accordance, permeabilization of
control fibroblast with Triton X-100 did not permit detec-
tion of LBPA in these cells (not shown). Application of
0.05% digitonin for cell permeabilization led to detection
of numerous LBPA-bearing endosomes in the control cells
(Figure 6C-C”), markedly improved detection of LBPA in
NPC cells (Figure 6B-B”), and increased the extent of colo-
calization of LBPA and GST-PFO staining (Figure 5). It
should be noted that treatment of cells with digitonin re-
moved substantial amounts of cholesterol from NPC cells
Figure 3 GST-PFO labels vesicles containing DiI-LDL in NPC cells. NPC fibroblasts (A-A”) and healthy control fibroblasts (B-B”) were cultured
in DMEM supplemented with delipidated 10% FBS for 72 h, incubated with 10 μg/ml DiI-LDL for 5 h and, after fixation and permeabilization,
processed for GST-PFO labeling. (A, B) GST-PFO staining, (A’, B’) fluorescence of DiI-LDL, (A”, B”) merged images. Inset in (A”) shows an enlargement
of a marked area. Scale bar, 20 μm.
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http://www.ojrd.com/content/9/1/64(see data below) and could affect colocalization studies.
Taken together, the data suggest that vesicles containing
cholesterol deposits detected by GST-PFO also contained
LAMP-1 and LBPA, the markers of late endosomes and
lysosomes.
In contrast, cis-Golgi cisterns decorated with anti-
golgin-84 antibody were located only in a close vicinity
of the nucleus and could be easily distinguished from
the GST-PFO-positive structures (Figure 7A-A”). There
were also no similarities between the patterns of staining
obtained with GST-PFO and with the anti-PDI antibody
which decorated the endoplasmic reticulum (Figure 7B-B”).
Moreover, antibodies against PMP70 of peroxisomes and
phalloidin-FITC, which labels actin filaments, exhibited
unique labeling patterns that were unlike the labeling ob-
tained with GST-PFO (Figure 7C-C” and 7D-D”). The lack
of colocalization of GST-PFO-positive vesicles with the in-
dicated organelle markers was reflected by low values of
the Pearson’s correlation and the overlap coefficients
which were in the range of 0.16-0.27 and 0.21-0.40, re-
spectively (Figure 5).Immunoelectron microscopy analysis of NPC cell labeling
with GST-PFO
To perform ultrastructural analysis of GST-PFO la-
beling, NPC cells were embedded in LR White resin.
Ultrastructural sections of the cells were processed for
post-embedding labeling with GST-PFO and anti-LAMP-
1 antibody. Figure 8A,B shows fragments of NPC cells
which contained numerous large vesicles filled with an
amorphous material and surrounded by abundant tubular
structures. These vesicles and their content as well as their
close surroundings were heavily decorated with gold parti-
cles attributed to GST-PFO (Figure 8A,B, arrows point to
accumulations of 6 nm gold particles). On this basis the
electron-opaque content of the vesicles can be ascribed to
cholesterol deposits. However, a fraction of cholesterol
was probably removed due to harsh conditions used for
dehydration and embedding of cells in the resin leaving
the interior of some of the lysosomes translucent. The
GST-PFO-decorated vesicles were also moderately labeled
with anti-LAMP-1 antibody which mainly stained the bor-
ders of the structures (Figure 8A, semicircles indicate
Figure 4 Colocalization of GST-PFO with LAMP-1 and filipin in NPC fibroblasts. Cholesterol visualized by GST-PFO (red) is present in
lysosomes identified by anti-LAMP-1 (green in A’-A”) and filipin (blue in B’-B”). (A”s1-s4) Merged images of optical sections of the cell shown in
(A-A”). The sections range from the basolateral (A”s1) to the apical (A”s4) part of the cell. (A”, B”) Merged images of (A-A’) and (B-B’), respectively.
Colocalization of GST-PFO and LAMP-1 is seen as yellow color in (A” and A”s1-s4) while pink color reflects colocalization of GST-PFO- and filipin-positive
structures in (B”). Scale bars, 20 μm.
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PFO and anti-LAMP-1 antibody was characteristic to
NPC cells. Ultrathin sections of control healthy fibroblasts
were devoid of large vesicles and were only scarcely la-
beled with GST-PFO. LAMP-1-decorating gold particles
were found as singlets and small clusters located mainly at
the borders of small vesicles (Figure 8C, semicircles).
Application of GST-PFO for cholesterol determination in
NPC cells by cellular ELISA
The presence of the GST tag in the fusion protein al-
lowed us to estimate the level of free cholesterol in cells
by cellular ELISA. The signal generated by GST-PFO/
anti-GST IgY-peroxidase increased in a linear mannerwith the number of cells, from 1×103 to 15×103 cells/
well (Figure 9A).
To examine whether Triton X-100 used for perme-
abilization of cells prior to GST-PFO labeling can extract
cholesterol from the deposits, fixed NPC cells were ex-
posed to the detergent in the concentration range from
0.03% to 0.2%. Treatment of cells with 0.05-0.2% Triton
X-100 did not significantly affect cholesterol detection
by GST-PFO (Figure 9B), indicating that cholesterol de-
posits in NPC cells are resistant to extraction with these
concentrations of detergent. In cells permeabilized with
0.03% Triton X-100 the amounts of cholesterol detec-
ted by GST-PFO were slightly lower in comparison to
these revealed at 0.05-0.2% Triton X-100 (Figure 9B),
Figure 5 Quantitation of colocalization of GST-PFO-positive structures and other cellular components in NPC fibroblasts. (A) Pearson’s
correlation coefficient, (B) overlap coefficient for co-immunostaining with GST-PFO and filipin or antibodies against LAMP1, LBPA, golgin-84, PDI,
PMP70 or phalloidin used as an actin filament marker. TX, Triton X-100, DiT, digitonin. Data shown are mean ± SEM.
Kwiatkowska et al. Orphanet Journal of Rare Diseases 2014, 9:64 Page 10 of 16
http://www.ojrd.com/content/9/1/64suggesting that in these condition the access of the
probe to cholesterol deposits could be limited. Finally,
GST-PFO failed to label NPC cells that were not perme-
abilized (Figure 9D). Therefore, permeabilization of cells
with Triton X-100 is required for the probe to gain access
to the cholesterol deposits in cells. This is in contrast
to filipin which stained cholesterol in non-permeabilized
cells (Figure 9D’-D”). Moreover, after treatment of cells
with 0.05% Triton X-100, cholesterol deposits became
sensitive to extraction with 3 mM methyl-β-cyclodextrin
which reduced subsequent GST-PFO binding by over 80%
(Figure 9B). The data indicate that permeabilization of the
plasma membrane and membranes of the intracellular
vesicles ensures high efficiency of cholesterol removal
from intracellular stores by methyl-β-cyclodextrin. In con-
trast to Triton X-100, permeabilization of cells with 0.05%
digitonin gave unsatisfactory results since it reduced GST-
PFO binding by about 50% (Figure 9B).
Using the cellular ELISA based on GST-PFO binding
to Triton X-100-permeabilized cells we compared choles-
terol levels in fibroblasts from NPC patients and a healthy
control. The level of free cholesterol in cells from two pa-
tients was fairly similar and was 2–2.4-fold higher than in
control fibroblasts (Figure 9C). Consistent with earlier
results, exposure of Triton X-100-permeabilized cells
to 3 mM methyl-β-cyclodextrin reduced the amount
of cholesterol by about 85% in both normal and NPC
cells (Figure 9C).
To estimate feasibility of using GSTO-PFO to distin-
guish between different biochemical phenotypes of NPC
cells, the results of PFO-based cellular ELISA were com-
pared with the results of routine filipin staining of cells
derived from various NPC patients. Cells obtained from
three persons (patients 1–3) unambiguously diagnosed
as NPC patients based on clinical symptoms and strongfilipin staining of fibroblasts displayed also strong GST-
PFO binding in cellular ELISA (Table 1). In addition,
the same analysis revealed relatively intense filipin and
GST-PFO staining of another fibroblast line (patient 4),
despite it was derived from a person whose preliminary
NPC diagnosis was not confirmed by genetic testing
(Table 1). Of interest, GST-PFO allowed to detect a
moderate increase of the free cholesterol level in fibro-
blasts from a person who was preliminarily classified as
a NPC patient based on a weak filipin staining and mild
clinical symptoms (patient 5) and the diagnosis was later
confirmed by a genetic approach (Table 1). Taken to-
gether, the data indicate that GST-PFO can be as useful
as filipin in detection of free cholesterol deposits in NPC
cells. In comparison, two other potential NPC diagnostic
methods, the measurement of total cholesterol content
in fibroblasts as well as the chitotriosidase activity in
serum of NPC patients yielded much less conclusive re-
sults. In general, the total cellular cholesterol content in
cells and the chitotriosidase activity in serum were ele-
vated in NPC patients but these parameters did not cor-
relate with the accumulation of free cholesterol in cells
or the severity of NPC clinical symptoms (Table 1). This
is in agreement with earlier findings that the chitotriosi-
dase activity can change with the age of NPC patients
and abnormal activity of the enzyme can be found also
in lysosomal storage disorders other than NPC [19,45].
On the other hand, defects in cholesterol esterification,
typical for NPC disease, can account for the discrepan-
cies between the total cholesterol level and the accumu-
lation of free cholesterol in NPC cells [39,46].
Discussion
Mutations in the NPC1 and NCP2 genes disturb the
trafficking of cholesterol in cells. These mutations are
Figure 6 GST-PFO labeling of NPC cells colocalizes with LBPA. NPC (A-B”) and healthy control fibroblasts (C-C”) were fixed, permeabilized
with 0.05% Triton X-100 (A-A”) or 0.05% digitonin (B-C”) and labeled with GST-PFO and anti-LBPA antibody. (A, B, C) GST-PFO labeling, (A’, B’, C’)
LBPA localization, (A”, B”, C”) merged images. TX, Triton X-100, DiT, digitonin. Scale bar, 20 μm.
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http://www.ojrd.com/content/9/1/64linked to a wide clinical spectrum of NPC disease and
their diversity seems to contribute to the heterogeneity
of NPC symptoms that range from severe to mild neuro-
logical defects, organomegaly and psychiatric symptoms
[3,14]. At the cellular level the abnormalities in cho-
lesterol trafficking are manifested by accumulation of
free unesterified cholesterol and disturbance in the me-
tabolism of some other lipids, particularly sphingolipids
[6,12,47]. At present, cholesterol deposits in NPC cells
are detected by staining of cells derived from skin biop-
sies with the polyene antibiotic filipin [3,16,39].In this report we demonstrate that cholesterol deposits
in fibroblasts from NPC patients can be conveniently vi-
sualized using a recombinant bacterial toxin, perfringoly-
sin O fused with a GST tag. GST-PFO stained cholesterol
in late endosomes/lysosomes in NPC fibroblasts perme-
abilized with 0.05% Triton X-100.
GST-PFO can easily be produced in large quantities in
E. coli and purified by simple one-step column affinity
chromatography. The probe is highly selective for choles-
terol, as we demonstrated by protein-lipid overlay assay
and surface plasmon resonance analysis. The recombinant
Figure 7 Negligible co-immunostaining of GST-PFO-positive structures and other organelles in NPC cells. (A-D) Distribution of GST-PFO-
positive structures, (A’-D’) patterns of staining by antibodies directed against golgin-84 (A’), PDI - an endoplasmic reticulum marker (B’), anti-
PMP70 – a peroxisomal marker (C’) and phalloidin labeling actin filaments (D’). (A”-D”) merging of the corresponding pairs of images displays
traces of the yellow color indicating different localization of GST-PFO-positive structures and the examined proteins. Scale bar, 20 μm.
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Figure 8 Immunoelectron microscopy analysis of GST-PFO staining in NPC and healthy fibroblasts. Ultrathin sections of NPC cells (A, B)
or control healthy fibroblasts (C) were subjected to post-embedding immunogold labeling with GST-PFO followed by anti-GST-biotin and anti-
biotin-gold antibodies (6 nm) together with rabbit anti-LAMP-1 and anti-rabbit-gold antibodies (10 nm). GST-PFO decorates material accumulated
in vesicles of NPC cells (arrows in A, B) while LAMP-1 is visualized mainly at the borders of vesicles in NPC and control fibroblasts (semicircles in
A and C).
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causes an efflux of 6-carboxyfluorescein from cholesterol-
containing liposomes, but not from those devoid of chol-
esterol (Figure 1B). PFO binds to membranes and causes
their permeabilization when the cholesterol content ex-
ceeds 30 mol% [25,26]. Therefore, the deposits of cho-
lesterol in NPC cells make them preferable targets of
GST-PFO. On the other hand, even though free chol-
esterol is present in non-NPC cells as well, its level is
too low to lead to any marked staining by GST-PFO.
The lytic activity of PFO does not affect the staining
of cells which were fixed before the treatment with
the probe. The presence of the GST tag allows detec-
tion of the probe bound to cholesterol in NPC cells
with a wide array of anti-GST antibodies. Dependingon the label conjugated with the anti-GST antibody var-
ious detection techniques can be used. In our hands, the
probe allowed unequivocal detection of cholesterol de-
posits in cells by immunofluorescence and immunoe-
lectron microscopy, and by cellular ELISA. The latter
approach is suitable for screening a large number of
samples and offers the possibility of a semiquantita-
tive analysis of free cholesterol accumulated in cells.
Cellular ELISA based on GST-PFO binding to cells
seems to be able to distinguish and quantify “variant”
biochemical phenotypes of NPC cells showing the le-
vel of cholesterol accumulation in the cells. Our preli-
minary data show that the GST-PFO probe is also suitable
for detection of free cholesterol by FACS analysis (not
shown).
Figure 9 Determination of cholesterol content in NPC cells by cellular ELISA. (A) Binding of GST-PFO to cholesterol increases proportionally
to the number of cells in the sample within the range of 1-15×103 cells/well. Triton X-100-permeabilized NPC fibroblasts were exposed to 5 μg/
ml GST-PFO followed by anti-GST IgY-peroxidase. Absorbance of the product of peroxidase activity is shown. (B) Permeabilization of cells with
Triton X-100 does not extract cholesterol from deposits. Fixed NPC cells were treated with 0.03%-0.2% Triton-X-100 (TX) or 0.05% digitonin, as
indicated, and processed for cellular ELISA using GST-PFO. In a series of experiments, prior to labeling with GST-PFO, cells were incubated with
3 mM methyl-β (CDX) for 60 min at 37°C. In these conditions prominent reduction in the binding of GST-PFO to cells is observed. (C) Significant
binding of GST-PFO to NPC fibroblasts. NPC cells and healthy controls were processed for cellular ELISA. When indicated, prior to labeling with
GST-PFO cells were incubated with 3 mM methyl-β-cyclodextrin. The results are presented as a ratio of absorbance at 450 nm and 595 nm. Data
are means ± SEM from four experiments. (D-D’) In non-permeabilized cells cholesterol deposits are not stained with GST-PFO (D) but are labeled
with filipin (D’). (D”): merged images of D and D’. Scale bar, 20 μm.
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ualization of free cholesterol deposits in NPC cells by
filipin [3,41]. Having a high affinity toward cholesterol,
filipin forms fluorescent complexes with the lipid [17].
However, the use of filipin has some drawbacks com-
pared to GST-PFO. The fluorescence of filipin requires
UV excitation, is easily scattered, and undergoes rapid
photobleaching [18]. The use of GST-PFO for labeling
does not pose such constraints, the probe can be de-
tected in a wide range of visible or infrared wavelengths,
and the fluorochromes available are fairly stable. OwingTable 1 Comparisons of different methods used in NPC disea







1 0.205 ± 0.031 + + + 115.72 ± 6.06
2 0.192 ± 0.042 + + + ND
3 0.181 ± 0.024 + + + 87.21 ± 14.80
4 0.166 ± 0.036 ++ 53.86 ± 5.41
5 0.130 ± 0.018 + 58.08 ± 11.91
Healthy 0.085 ± 0.004 − 14.63 ± 1.12
GST-PFO binding, filipin labeling, and total cholesterol content was estimated in cu
patients and a healthy control. Results of two or three assays run in triplicates are sto these properties, GST-PFO also facilitates studies on
the nature of vesicles harboring cholesterol deposits in
NPC cells, which is another advantage of GST-PFO over
filipin.
In 2003–2004 Chang’s group made an attempt to use
a PFO derivative for cholesterol detection in NPC cells.
The so-called BCθ probe was obtained by proteolytic di-
gestion of PFO and biotinylation of the complex of the
two resulting fragments [48]. This probe was used to
stain a Chinese hamster ovary cell line lacking the NPC1




1515 -1810 Typical symptoms
465 - 783 Typical symptoms
212 Typical symptoms
ND Qualified initially as NPC, not confirmed genetically
286 - 323 Moderate symptoms - progressing with age,
genetically confirmed
120 - 150 N/A
ltured skin fibroblasts, while the chitotriosidase activity in serum of NPC
hown as mean ± SEM when indicated.
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http://www.ojrd.com/content/9/1/64brains of NPC mice. The authors showed that BCθ stained
mainly “cholesterol-rich domains” inside the cells [27,28].
The probe entered the cell without prior permeabilization
with detergents. Instead, it was shown that the cells be-
came permeable to BCθ when fixed with 4% paraformal-
dehyde. This approach is unusual, especially taking into
account the relatively high molecular mass of BCθ (ca.
57 kDa) and streptavidin-Texas Red (forms tetramers of
ca. 76 kDa) used for analysis. In these conditions, both the
entry of proteins across the plasma membrane, and par-
ticularly across the endosomal/lysosomal membrane and
washout of excess protein, are impeded. Perhaps for these
reasons the BCθ-positive structures were not well distin-
guished. In our studies, beside fixation, the cells were add-
itionally permeabilized with 0.05% Triton X-100. Omitting
the detergent treatment excluded any labeling of the cells
with GST-PFO (ca. 78 kDa). On the other hand, 0.05%-
02% Triton X-100 did not solubilize the cholesterol de-
posits in NPC cells, judging from the intense filipin and
GST-PFO staining and cellular ELISA analysis. Per-
meabilization of cells with Triton X-100 increased the
accessibility of cholesterol deposits to GST-PFO. Choles-
terol deposits were also freely accessible to methyl-β-
cyclodextrin which significantly reduced their level in the
cells. This effect was not achieved in non-permeabilized
cells exposed to cyclodextrin after fixation with 4% para-
formaldehyde [24]. Using permeabilized cells we were able
to reveal that vesicles labeled by GST-PFO were also posi-
tive for LAMP-1 and LBPA. LAMP-1 is generally accepted
as a marker of lysosomes [49] while LBPA accumulates in
the inner membranes of multivesicular bodies [43]. In
contrast to earlier reports on a high degree of colocaliza-
tion of filipin-stained vesicles with LBPA [44] in our hands
vesicles labeled by GST-PFO displayed significant but not
complete overlapping with LBPA staining. This could en-
sue from technical problems of cell permeabilization
which is hard to optimize for both lipids and possibly also
from the fact that we work on cells cultured for 72 h in
delipidated FBS, which could affect cellular distribu-
tion of LBPA. Our data indicate that GST-PFO-positive
structures bear markers of late endosomes/lysosomes but
not those of endoplasmic reticulum, Golgi apparatus or
peroxisomes.
Altogether, the data indicate that GST-PFO is a con-
venient and reliable probe for detection of cholesterol
deposits in cells of NPC patients.
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